PHARMAX HOLDINGS LIMITED
Summary
PHARMAX HOLDINGS LIMITED is registered in Cyprus and entered in the “Companies Section” under number ΗΕ 295375. Its legal form is Ιδιωτική Εταιρεία Περιορισμένης Ευθύνης με μετοχές. According to GLEIF, its ultimate parent is PENTA INVESTMENTS LIMITED (Cyprus), and its direct parent is DR.MAX GROUP HOLDINGS PLC (Cyprus). That group has 23 subsidiaries with LEIs in 3 countries, 6 of them in Cyprus. It has 5 direct subsidiaries in GLEIF data; 2 of them have a lapsed LEI. The LEI was first issued on 16 Jan 2018 and the record was last updated on 21 Sep 2026; the next renewal is due by 21 Sep 2027.
Written from GLEIF data using fixed, reviewed sentence templates.
Data-quality notes (AssetCensus analysis)
No data-quality notes for this entity in this data release.
Company details
| Legal form | Ιδιωτική Εταιρεία Περιορισμένης Ευθύνης με μετοχές |
|---|---|
| Register | Companies Section · Register website |
| Registration number | ΗΕ 295375 |
| Registration authority | Department of Registrar of Companies and Official Receiver |
| Jurisdiction | Cyprus |
| Registered address | Agias Fylaxeos & Polygnostou, 212, C & I CENTER BUILDING, 3082 Limassol, Cyprus |
| Category | company or other legal entity |
| Status | active |
| Founded (per GLEIF) | 14 Oct 2011 |
| LEI | 315700V2745LB573IO65 |
| LEI status | active |
| LEI first issued | 16 Jan 2018 |
| LEI record last updated | 21 Sep 2026 |
| Next LEI renewal | 21 Sep 2027 |
| Corroboration of the LEI record | fully corroborated |
Group membership
3 subsidiaries in 3 countries report PHARMAX HOLDINGS LIMITED itself as their ultimate parent, although PHARMAX HOLDINGS LIMITED reports a different ultimate parent.
View the whole group: 3 subsidiaries in 3 countriesRelationship to the parent
| Direct parent | Ultimate parent | |
|---|---|---|
| Parent | DR.MAX GROUP HOLDINGS PLC | PENTA INVESTMENTS LIMITED |
| Accounting period | 1 Jan 2025 to 31 Dec 2025 | 1 Jan 2025 to 31 Dec 2025 |
| Evidence | consolidated accounts | supporting documents |
| Corroboration | fully corroborated | supplied by the entity only |
| Accounting standard | IFRS | IFRS |
| Consolidation percentage reported to GLEIF | 100.00% | 100.00% |
| Relationship start | 28 May 2013 | 28 May 2013 |
| Recorded at GLEIF since | 18 Sep 2026 | 18 Sep 2026 |
| Last updated | 21 Sep 2026 | 21 Sep 2026 |
| Record status | current | current |
Direct subsidiaries (5)
- Baramoore International s.r.o. Czechia · Praha 1
- ViaPharma s.r.o. Czechia lapsed · Praha
- ČESKÁ LÉKÁRNA HOLDING, a.s. Czechia · Brno
- BRL Center Polska Spółka z ograniczoną odpowiedzialnością Poland lapsed · Wrocław
- Dr. Max Holding SK, a.s. Slovakia · Bratislava - mestská časť Petržalka
Other subsidiaries of the same direct parent (2)
- Dr. Max Funding CR, s.r.o. Czechia
- Dr. Max Funding, s.r.o. Slovakia